Related Experiment Video
Updated: Jul 16, 2026

Electrophoretic Analysis of Replication Through Structure-Prone DNA Repeats Within the SV40-Based Human Episome
Published on: September 13, 2024
Repression of intestinal drug metabolizing enzymes by the SV40 large T antigen
M T Sáenz-Robles1, D Toma, P Cantalupo
1Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA.
Abstract:
Toxic compounds such as carcinogens are removed from the body by the action of a series of detoxifying enzymes and transporters expressed in the liver and the small intestine. We have found that intestinal epithelial cells expressing the SV40 large T antigen (TAg) contain significantly lower levels of mRNAs, encoding several drug metabolizing/detoxifying enzymes and transporters compared to their non-transgenic littermates. In addition, TAg blocks the induction of these mRNAs by xenobiotics. The repression depends on an intact LXCXE motif in TAg, suggesting that inactivation of the retinoblastoma (Rb) family of tumor suppressors plays a role in the process. These results imply that a functional Rb pathway in the intestine is necessary for the expression of the detoxification system used to clear carcinogens, and suggest that loss of this tumor suppressor might alter susceptibility to chemical injury. In addition, the effect of TAg on the detoxification pathway appears to be tissue-specific, as its ectopic expression in the liver failed to suppress the P450 enzymes. The TAg-mediated suppression of drug metabolizing/detoxifying enzymes may have broad implications in the metabolism and mechanism of action of both carcinogens and prescription drugs.
Insights
The SV40 large T antigen (TAg) in intestinal cells lowers detoxification enzymes, impacting carcinogen and drug metabolism. This suggests a functional retinoblastoma pathway is vital for intestinal detoxification.
Area of Science:
- Biochemistry
- Molecular Biology
- Toxicology
Background:
- Detoxification enzymes and transporters in the liver and small intestine eliminate toxic compounds like carcinogens.
- The SV40 large T antigen (TAg) is a viral protein known to interfere with cellular processes.
Purpose of the Study:
- To investigate the effect of SV40 large T antigen (TAg) expression on detoxification systems in intestinal epithelial cells.
- To determine the role of the retinoblastoma (Rb) pathway in TAg-mediated suppression of detoxification enzymes.
Main Methods:
- Comparison of mRNA levels for drug metabolizing/detoxifying enzymes and transporters in TAg-expressing intestinal cells versus non-transgenic littermates.
- Assessment of TAg's ability to block xenobiotic induction of these mRNAs.
- Analysis of the role of the LXCXE motif in TAg and its interaction with the Rb family of tumor suppressors.
Main Results:
- Intestinal epithelial cells expressing TAg showed significantly reduced mRNA levels for key detoxification enzymes and transporters.
- TAg inhibited the induction of these detoxification-related mRNAs by xenobiotics.
- The repression was dependent on an intact LXCXE motif in TAg, implicating Rb pathway inactivation.
- TAg expression in the liver did not suppress P450 enzymes, indicating tissue-specific effects.
Conclusions:
- A functional retinoblastoma pathway in the intestine is essential for the proper expression of the carcinogen detoxification system.
- Loss of Rb tumor suppressor function may increase susceptibility to chemical injury in the intestine.
- TAg-mediated suppression of detoxification enzymes has significant implications for understanding carcinogen and drug metabolism.
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
10:13Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses
Published on: May 6, 2019
Related Concept Videos
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Non-LTR Retrotransposons
Drug Metabolism: Phase II Reactions
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Size and Structure of Viral Genomes